These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
514 related items for PubMed ID: 15966978
1. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. Schoening TE, Wagner J, Arvand M. Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978 [Abstract] [Full Text] [Related]
2. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women. Pinheiro S, Radhouani H, Coelho C, Gonçalves A, Carvalho E, Carvalho JA, Ruiz-Larrea F, Torres C, Igrejas G, Poeta P. Microb Drug Resist; 2009 Jun; 15(2):121-4. PubMed ID: 19432524 [Abstract] [Full Text] [Related]
3. High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus. DiPersio LP, DiPersio JR. Diagn Microbiol Infect Dis; 2006 Jan; 54(1):79-82. PubMed ID: 16368478 [Abstract] [Full Text] [Related]
4. Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family. Florindo C, Viegas S, Paulino A, Rodrigues E, Gomes JP, Borrego MJ. Clin Microbiol Infect; 2010 Sep; 16(9):1458-63. PubMed ID: 19886900 [Abstract] [Full Text] [Related]
5. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Hsueh PR, Teng LJ, Lee LN, Ho SW, Yang PC, Luh KT. Antimicrob Agents Chemother; 2001 Nov; 45(11):3205-8. PubMed ID: 11600380 [Abstract] [Full Text] [Related]
6. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand. Malbruny B, Werno AM, Anderson TP, Murdoch DR, Leclercq R. J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693 [Abstract] [Full Text] [Related]
7. Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae. Culebras E, Rodríguez-Avial I, Betriu C, Picazo JJ. J Antimicrob Chemother; 2005 Nov; 56(5):836-40. PubMed ID: 16186169 [Abstract] [Full Text] [Related]
8. Anti-microbial susceptibility of Streptococcus spp. isolated from bovine mastitis in Argentina. Denamiel G, Llorente P, Carabella M, Rebuelto M, Gentilini E. J Vet Med B Infect Dis Vet Public Health; 2005 Apr; 52(3):125-8. PubMed ID: 15876224 [Abstract] [Full Text] [Related]
9. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain. Merino Díaz L, Torres Sánchez MJ, Aznar Martín J. Clin Microbiol Infect; 2008 Jan; 14(1):85-7. PubMed ID: 18034859 [Abstract] [Full Text] [Related]
12. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J. Microb Drug Resist; 2004 Jan; 10(1):31-6. PubMed ID: 15140391 [Abstract] [Full Text] [Related]
13. Invasive neonatal GBS infections from an area-based surveillance study in Italy. Imperi M, Gherardi G, Berardi A, Baldassarri L, Pataracchia M, Dicuonzo G, Orefici G, Creti R. Clin Microbiol Infect; 2011 Dec; 17(12):1834-9. PubMed ID: 21722258 [Abstract] [Full Text] [Related]
14. Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B streptococcus isolates. Clifford V, Heffernan HM, Grimwood K, Garland S, Australasian GBS Resistance Study Group. Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):328-32. PubMed ID: 21806568 [Abstract] [Full Text] [Related]
15. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. Domelier AS, van der Mee-Marquet N, Arnault L, Mereghetti L, Lanotte P, Rosenau A, Lartigue MF, Quentin R. J Antimicrob Chemother; 2008 Dec; 62(6):1227-33. PubMed ID: 18786936 [Abstract] [Full Text] [Related]
16. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea. Uh Y, Shin DH, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY. J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924 [Abstract] [Full Text] [Related]
17. Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany. Asmah N, Eberspächer B, Regnath T, Arvand M. J Med Microbiol; 2009 Feb; 58(Pt 2):222-227. PubMed ID: 19141740 [Abstract] [Full Text] [Related]
18. The outpatient institutional antibiogram does not accurately reflect the susceptibility of prepartum group B streptococcal isolates to erythromycin and clindamycin. Gray KL, Fulcher LC, McElmeel ML, Xenakis EM, Jorgensen JH. Diagn Microbiol Infect Dis; 2011 Dec; 71(4):457-9. PubMed ID: 21982562 [Abstract] [Full Text] [Related]
19. Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts. Dogan B, Schukken YH, Santisteban C, Boor KJ. J Clin Microbiol; 2005 Dec; 43(12):5899-906. PubMed ID: 16333073 [Abstract] [Full Text] [Related]
20. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain]. Rodríguez-Zurita ME, Solís del Baño S, Robres Guillén P, González Praetorius A, Gimeno Fernández C, Pérez Pomata MT, Bisquert Santiago J. Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]